openPR Logo
Press release

Yeast Beta Glucan Market: Growth Drivers and Market Forecast

Yeast Beta Glucan Market

Yeast Beta Glucan Market

The yeast beta glucan market is projected to grow at a 5.1% CAGR, reaching US$ 991.5 million by 2034. This expansion is driven by increasing awareness of health and wellness, coupled with the rising demand for natural ingredients and sustainable solutions.

The yeast beta glucan market is witnessing dynamic growth fueled by the escalating demand for natural, functional, and sustainable ingredients across diverse industries. Rising product demand in applications such as animal feed and functional food is anticipated to be a key market driver over the projected period.

Request Sample Report and Drive Impactful Decisions: https://www.futuremarketinsights.com/reports/sample/rep-gb-18858

The need for functional foods is growing worldwide due to several variables, including the surging elderly population and increasing prevalence of chronic diseases. Women and children are most likely to have low immunity, particularly in developing nations. The market for products that help increase immunity is predicted to rise due to growing consumer knowledge of health issues.

Preventive regimens are becoming increasingly popular among consumers, as opposed to post-treatment drugs. By 2034, product innovations, especially in the nutrition sector, are expected to fuel demand for medications and nutraceuticals containing yeast beta glucan.

Robust research & development activities and collaborations among key players underscore a commitment to unlocking new applications and formulations. With a focus on sustainability and clean-label preferences, yeast beta glucan is poised to play a pivotal role in shaping the future of health-centric and eco-conscious industries.

"Despite the product's excellent nutritional value, its compatibility with other culinary ingredients is difficult for manufacturers. Furthermore, it is challenging for manufacturers to reduce the chance of deterioration and maintain the nutritious composition during processing." - Nandini Roy Choudhury, Client Partner at Future Market Insights

Key Takeaways from the Yeast Beta Glucan Market Report:

The yeast beta glucan market is projected to grow at a CAGR of 5.1% during the forecast period.
The United States yeast beta glucan market is expected to reach US$ 166.1 million by 2034.
Based on type, the 1,3-glucan segment is expected to hold a market share of 51.2% in 2024.
China is expected to surge at a CAGR of 8.1% from 2024 to 2034.
The United Kingdom is projected to rise at 5.1% CAGR through the forecast period.

Key Companies Profiled

Cargill, Incorporated
EMD Millipore
Lallemand, Inc.
Van Wankum Ingredients
Biorigin
Angel Yeast Co., Ltd.
Kerry Group plc
Leiber
Lesaffre Human Care
Specialty Biotech Co., Ltd.

Key companies are expanding their product portfolios and employing advertising, partnerships, acquisitions, agreements, and mergers to maintain market relevance and drive growth in the yeast beta glucan market.

For instance,

In 2020, Angel Yeast expanded its yeast beta glucan production capacity, responding to escalating product demand.
In December 2020, Lallemand Bio-Ingredients expanded its beta glucans portfolio by acquiring Biotec BetaGlucans (BBG), a subsidiary of ArticZymes Technologies.

Download the full report for in-depth insights. https://www.futuremarketinsights.com/reports/yeast-beta-glucan-market

Yeast Beta Glucan Market Segmentation by Category

By Type:

1,3-glucan
1,6-glucan
By Form:

Soluble
Insoluble

By End-use Application:

Food and Beverage Industry
Cosmetics and Skincare Industry
Animal Feed Industry
Agriculture Industry
Pharmaceutical

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

Have a Look at the Related Reports of the Food and Beverage Domain:

Beta-glucans Market: https://www.futuremarketinsights.com/reports/beta-glucans-market

Oat Beta-Glucan : https://www.futuremarketinsights.com/reports/oat-beta-glucan-market

Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Yeast Beta Glucan Market: Growth Drivers and Market Forecast here

News-ID: 3798744 • Views:

More Releases from Future Market Insights Inc

Endoscopy Fluid Management Systems Market Poised for Significant Growth, Projected to Surpass USD 1.1 Billion by 2035 Key Players Hologic Inc, B. Braun Medical Inc., Medtronics Plc., Cantel Medical Corporation and Others
Endoscopy Fluid Management Systems Market Poised for Significant Growth, Project …
The global Endoscopy Fluid Management Systems Market is on a trajectory of significant expansion, with a new market forecast projecting its value to more than double over the next decade. According to the latest analysis, the market, valued at an estimated USD 550.3 million in 2025, is expected to surge to USD 1,123.7 million by 2035. This robust growth represents a compound annual growth rate (CAGR) of 7.4% and is
NGS Sample Preparation Market Poised for Explosive Growth, Set to Triple by 2035 Key Players Macrogen, Inc., Eurofins Scientific, Illumina, Inc., F Hoffman-La Roche AG and Others
NGS Sample Preparation Market Poised for Explosive Growth, Set to Triple by 2035 …
A new market analysis projects the global Next-Generation Sequencing (NGS) Sample Preparation market to experience a significant surge, forecasting a valuation of USD 7.0 billion by 2035. This marks a substantial increase from its estimated USD 1.9 billion value in 2025, reflecting a robust Compound Annual Growth Rate (CAGR) of 13.7% over the decade. The findings underscore the pivotal role of sample preparation in the expanding field of genomics, driven
Eye and Face Protection Market USD 2.3 Billion by 2035 Key Players Medline Industries, Cardinal Health Inc., DMC Medical Ltd., Lifelong Meditech (Group) and Others
Eye and Face Protection Market USD 2.3 Billion by 2035 Key Players Medline Indus …
The global Eye and Face Protection Market is poised for significant expansion, with a new forecast predicting it will grow from an estimated USD 859.3 million in 2025 to USD 2,332.2 million by 2035. This robust growth trajectory represents a compound annual growth rate (CAGR) of 10.5% over the forecast period, driven by a confluence of rising industrial safety awareness, stringent regulatory mandates, and technological innovation. Click Here for More Information:-
Dermatology Excimer Lasers Market to Nearly Triple by 2035 Key Players Cutera, Inc., The Daavlin Company, Shenzhen GSD Tech Co., Ltd., DEKA Research & Development Corp and Others
Dermatology Excimer Lasers Market to Nearly Triple by 2035 Key Players Cutera, I …
The global market for dermatology excimer lasers is projected to surge from an estimated USD 109.7 million in 2025 to a remarkable USD 317.1 million by 2035, marking a significant compound annual growth rate (CAGR) of 11.2%. This substantial expansion is being fueled by a combination of factors, including the rising global prevalence of chronic skin conditions and a growing preference for advanced, targeted therapies. Click Here for More Information:- https://www.futuremarketinsights.com/reports/dermatology-excimer-lasers-market Dermatology

All 5 Releases


More Releases for Beta

Beta-lactam and Beta-lactamase Inhibitors Market Emerging Trends and Growth Pros …
The global beta-lactam and beta-lactamase inhibitors market is valued at approximately $60 billion in 2024, driven by the rising prevalence of bacterial infections and the increasing resistance to traditional antibiotics. The market is projected to reach around $85 billion by 2034, reflecting a robust growth trajectory. This results in a Compound Annual Growth Rate (CAGR) of approximately 6.5% during the forecast period of 2025-2034. Exactitude Consultancy., Ltd. released a research report
Beta-Lactams & Beta-Lactamase Inhibitors: A Persistent Powerhouse in the Antibio …
The antibiotics market, despite facing challenges, remains a critical sector in global healthcare. Within this landscape, the Beta-Lactam and Beta-Lactamase Inhibitor segment stands out as a high-opportunity area, driven by the continued prevalence of bacterial infections and the ongoing fight against antimicrobial resistance (AMR). Market Dynamics and Growth Drivers Beta-lactam antibiotics, including penicillins and cephalosporins, have been the cornerstone of antibacterial therapy for decades. Their broad spectrum of activity and generally favorable
apuem - beta
Today the beta phase of apuem starts. Our goal is to create the largest web app collection, and for that we need your help. So if you know a useful online tool that you like to use, suggest it to us. See more: apuem.com/suggestions We appreciate any kind of participation. Thank you very much! Apuem Finkenhofstraße 27 60322 Frankfurt am Main Germany Jacob Kearson support@apuem.com More Information: apuem.com/contact We and our community search for the best web apps
Beta-lactam and Beta-lactamase Inhibitors Market to Reach $34,170 Million by 202 …
Global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028. The cephalosporin segment accounted more than two-fifths of the total beta-lactam and beta-lactamase inhibitors market share in 2018. Download Report Sample PDF @ https://www.alliedmarketresearch.com/request-sample/5427 Beta-lactam and beta-lactamase inhibitors are chemical compounds of natural or semi-synthetic or synthetic origin. They inhibit
Beta-lactam and Beta-lactamase Inhibitors Market Outlook from 2019 to 2028
"According to a new report published titled, ""India Heat Exchangers Market by Type, Material of Construction, and End-User Industry: Opportunity Analysis and Industry Forecast, 2019-2026,"" the India heat exchangers market accounted for revenue of $454.4 million in 2018, and is anticipated to generate $890.0 million by 2026. The market is projected to grow at a CAGR of 8.6% from 2019 to 2026. Heat exchangers are devices that transfer energy between fluids
Beta-lactam and Beta-lactamase Inhibitors Market Size, Share, Development by 202 …
Global Info Research offers a latest published report on Beta-lactam and Beta-lactamase Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Beta-lactam and Beta-lactamase Inhibitors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Beta-lactam and Beta-lactamase